PFIZER, INC. |
Market Closed -
Other stock markets
|
Pre-market 07:12:32 am | |||
| 28.3 USD | -2.01% |
|
28.26 | -0.14% |
| May. 27 | US, European nations consider vaccinating workers exposed to bird flu | RE |
| May. 24 | Novavax awaits FDA decision on whether its next COVID shot can be offered in US | RE |
ETFs positioned on Pfizer, Inc.
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 14.74% | 254 M€ | +12.51% | - | |
| 9.37% | 17 M€ | +7.15% | - | |
| 3.49% | 9 M€ | -.--% | - | |
| 2.99% | 23 M€ | +15.68% | - | |
| 2.80% | 2 M€ | -.--% | - | |
| 2.70% | 5 M€ | -72.95% | - | |
| 2.45% | 562 M€ | -2.20% | ||
| 2.13% | 2 M€ | 0.00% | ||
| 1.97% | 0 M€ | -.--% | ||
| 1.50% | 24 M€ | -0.14% | - | |
| 1.50% | 26 M€ | 0.00% | - | |
| 1.50% | 224 M€ | +3.27% | - | |
| 1.48% | 1 M€ | +2.21% | - | |
| 1.48% | 8 M€ | +3.71% | ||
| 1.40% | 9 M€ | -4.31% | - | |
| 1.24% | 85 M€ | 0.00% | - | |
| 1.24% | 13,519 M€ | +4.52% | ||
| 1.07% | 375 M€ | +8.15% | ||
| 1.04% | 800 M€ | +3.78% | ||
| 1.00% | 26 M€ | +22.96% | - | |
| 0.98% | 0 M€ | 0.00% | - | |
| 0.90% | 6 M€ | +17.98% | - |
Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows:
- primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.;
- specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.;
- oncology products (12.1%);
- other (1.3%).
At the end of 2022, the group had more than 35 manufacturing sites worldwide.
Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Sector
Pharmaceuticals
Calendar
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
C+
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
28.3
USD
Average target price
31.92
USD
Spread / Average Target
+12.78%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -1.70% | 160B | |
| +38.59% | 727B | |
| -7.89% | 347B | |
| +15.66% | 319B | |
| +0.24% | 274B | |
| +13.21% | 238B | |
| +7.09% | 204B | |
| -6.09% | 203B | |
| +4.23% | 161B | |
| -2.16% | 120B |
- Stock Market
- Equities
- PFE Stock
- Funds and ETFs Pfizer, Inc.
